A citation-based method for searching scientific literature

Mirco Pistelli, Mariagrazia De Lisa, Zelmira Ballatore, Miriam Caramanti, Alessandra Pagliacci, Nicola Battelli, Francesca Ridolfi, Matteo Santoni, Elena Maccaroni, Raffaella Bracci, Alfredo Santinelli, Tommasina Biscotti, Rossana Berardi, Stefano Cascinu. BMC Cancer 2015
Times Cited: 82







List of co-cited articles
553 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.
Basem Azab, Vijaya R Bhatt, Jaya Phookan, Srujitha Murukutla, Nina Kohn, Terenig Terjanian, Warren D Widmann. Ann Surg Oncol 2012
362
28

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Arnoud J Templeton, Mairéad G McNamara, Boštjan Šeruga, Francisco E Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz-Amit, Guru Sonpavde, Jennifer J Knox, Ben Tran,[...]. J Natl Cancer Inst 2014
26

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.
Basem Azab, Neeraj Shah, Jared Radbel, Pamela Tan, Vijaya Bhatt, Steven Vonfrolio, Ayman Habeshy, Antonio Picon, Scott Bloom. Med Oncol 2013
173
26

Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
C-H Koh, N Bhoo-Pathy, K-L Ng, R S Jabir, G-H Tan, M-H See, S Jamaris, N A Taib. Br J Cancer 2015
200
25

Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
Ahmet Dirican, Betul Bolat Kucukzeybek, Ahmet Alacacioglu, Yuksel Kucukzeybek, Cigdem Erten, Umut Varol, Isil Somali, Lutfiye Demir, Ibrahim Vedat Bayoglu, Yasar Yildiz,[...]. Int J Clin Oncol 2015
104
24

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Josee-Lyne Ethier, Danielle Desautels, Arnoud Templeton, Prakesh S Shah, Eitan Amir. Breast Cancer Res 2017
282
24

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.
Minya Yao, Yu Liu, Hailong Jin, Xiaojiao Liu, Kezhen Lv, Haiyan Wei, Chengyong Du, Shuqian Wang, Bajin Wei, Peifen Fu. Onco Targets Ther 2014
64
29


Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer.
Yuka Asano, Shinichiro Kashiwagi, Naoyoshi Onoda, Satoru Noda, Hidemi Kawajiri, Tsutomu Takashima, Masahiko Ohsawa, Seiichi Kitagawa, Kosei Hirakawa. Ann Surg Oncol 2016
84
21

Cancer-related inflammation.
Alberto Mantovani, Paola Allavena, Antonio Sica, Frances Balkwill. Nature 2008
19

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
Graeme J K Guthrie, Kellie A Charles, Campbell S D Roxburgh, Paul G Horgan, Donald C McMillan, Stephen J Clarke. Crit Rev Oncol Hematol 2013
824
19

Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer.
Jin Hong, Yan Mao, Xiaosong Chen, Li Zhu, Jianrong He, Weiguo Chen, Yafen Li, Lin Lin, Xiaochun Fei, Kunwei Shen. Tumour Biol 2016
26
53

Immunity, inflammation, and cancer.
Sergei I Grivennikov, Florian R Greten, Michael Karin. Cell 2010
15


Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer.
S Chae, K M Kang, H J Kim, E Kang, S Y Park, J H Kim, S H Kim, S W Kim, E K Kim. Curr Oncol 2018
35
37

Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Dilan A Patel, Jing Xi, Jingqin Luo, Bilal Hassan, Shana Thomas, Cynthia X Ma, Jian L Campian. Breast Cancer Res Treat 2019
40
32

Inflammation and cancer.
Lisa M Coussens, Zena Werb. Nature 2002
14

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
S Krenn-Pilko, U Langsenlehner, E-M Thurner, T Stojakovic, M Pichler, A Gerger, K S Kapp, T Langsenlehner. Br J Cancer 2014
173
14

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
14

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Arife Ulas, Nilufer Avci, Tugba Kos, Erdem Cubukcu, Omer Fatih Olmez, Nilufer Bulut, Mustafa Degirmenci. J BUON 2015
31
38

Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Jie Chen, Qiwen Deng, Yuqin Pan, Bangshun He, Houqun Ying, Huiling Sun, Xian Liu, Shukui Wang. FEBS Open Bio 2015
71
16

Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients.
Oktay Bozkurt, Halit Karaca, Veli Berk, Mevlude Inanc, Ayse Ocak Duran, Ersin Ozaslan, Mahmut Ucar, Metin Ozkan. J BUON 2015
19
63

Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
Mu-Xing Li, Xue-Min Liu, Xu-Feng Zhang, Jian-Fei Zhang, Wan-Li Wang, Ying Zhu, Jian Dong, Ji-Wen Cheng, Zheng-Wen Liu, Le Ma,[...]. Int J Cancer 2014
298
13

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
Sherene Loi, Nicolas Sirtaine, Fanny Piette, Roberto Salgado, Giuseppe Viale, Françoise Van Eenoo, Ghizlane Rouas, Prudence Francis, John P A Crown, Erika Hitre,[...]. J Clin Oncol 2013
13

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.
Seth B Coffelt, Kelly Kersten, Chris W Doornebal, Jorieke Weiden, Kim Vrijland, Cheei-Sing Hau, Niels J M Verstegen, Metamia Ciampricotti, Lukas J A C Hawinkels, Jos Jonkers,[...]. Nature 2015
928
13

The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8.
Joseph E De Larco, Beverly R K Wuertz, Leo T Furcht. Clin Cancer Res 2004
269
13



Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
12


Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer.
Chao Liu, Zhou Huang, Qiusheng Wang, Bing Sun, Lijuan Ding, Xiangying Meng, Shikai Wu. Onco Targets Ther 2016
27
37

Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
Uiju Cho, Hong Sik Park, So Young Im, Chang Young Yoo, Ji Han Jung, Young Jin Suh, Hyun Joo Choi. PLoS One 2018
58
17

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
Brian D Lehmann, Joshua A Bauer, Xi Chen, Melinda E Sanders, A Bapsi Chakravarthy, Yu Shyr, Jennifer A Pietenpol. J Clin Invest 2011
10

Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
Kiichiroh Nakano, Mitsuchika Hosoda, Mitsugu Yamamoto, Hiroko Yamashita. Anticancer Res 2014
30
30


Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
Christoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, Andrea Groselj-Strele, Katharina Eberhard, Hellmut Samonigg, Hans Loibner, Nadia Dandachi, Marija Balic. BMC Cancer 2015
35
25

The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis.
Bajin Wei, Minya Yao, Chunyang Xing, Wei Wang, Jia Yao, Yun Hong, Yu Liu, Peifen Fu. Onco Targets Ther 2016
79
11

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis.
Michele Orditura, Gennaro Galizia, Anna Diana, Ciro Saccone, Luigi Cobellis, Jole Ventriglia, Francesco Iovino, Ciro Romano, Floriana Morgillo, Lavinia Mosca,[...]. ESMO Open 2016
45
20


Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
Sahar M A Mahmoud, Emma Claire Paish, Desmond G Powe, R Douglas Macmillan, Matthew J Grainge, Andrew H S Lee, Ian O Ellis, Andrew R Green. J Clin Oncol 2011
929
9

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.
Marisa M Queen, Randall E Ryan, Ryan G Holzer, Cynthia R Keller-Peck, Cheryl L Jorcyk. Cancer Res 2005
259
9

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth.
A McGarry Houghton, Danuta M Rzymkiewicz, Hongbin Ji, Alyssa D Gregory, Eduardo E Egea, Heather E Metz, Donna B Stolz, Stephanie R Land, Luiz A Marconcini, Corrine R Kliment,[...]. Nat Med 2010
450
9

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
9

Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer.
Yasemin Benderli Cihan, Alaettin Arslan, Mehmet Faik Cetindag, Hasan Mutlu. Asian Pac J Cancer Prev 2014
31
25



Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.
Yoji Kishi, Scott Kopetz, Yun Shin Chun, Martin Palavecino, Eddie K Abdalla, Jean-Nicolas Vauthey. Ann Surg Oncol 2009
259
8

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.
Carsten Denkert, Sibylle Loibl, Aurelia Noske, Marc Roller, Berit Maria Müller, Martina Komor, Jan Budczies, Silvia Darb-Esfahani, Ralf Kronenwett, Claus Hanusch,[...]. J Clin Oncol 2010
8

Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
H R Ali, E Provenzano, S-J Dawson, F M Blows, B Liu, M Shah, H M Earl, C J Poole, L Hiller, J A Dunn,[...]. Ann Oncol 2014
435
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.